References
- Boyle, W.J., Simonet, W.S., Lacey, D.L. Osteoclastdifferentiation and activation. Nature. 423: 337-342, 2003 https://doi.org/10.1038/nature01658
- Wagner, E.F., Karsenty, G. Genentic control of skeletaldevelopment. Curr. Opin. Genet. Dev. 11: 527-532, 2001 https://doi.org/10.1016/S0959-437X(00)00228-8
- Karsenty, G., Wagner, E.F. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell. 4: 389-406, 2002 https://doi.org/10.1016/S1534-5807(02)00157-0
- Wei, S., Kitaura, H., Zhou, P., Ross, F.P., Teitelbaum, S.L. IL-1 mediates TNF-induced osteoclastogenesis. J. Clin. Invest. 115: 282-290, 2005 https://doi.org/10.1172/JCI23394
- Miyaura, C., Inada, M., Matsumoto, C., Ohshiba, T., Uozumi, N., Shimizu, T., Ito, A. An essential role of cytosolic phospholipase A2alpha in prostaglandin E2-mediated bone resorption associated with inflammation. J. EXP. Med. 197: 1303-1310, 2003 https://doi.org/10.1084/jem.20030015
- Takeda, S., Yoshizawa, T., Nagai, Y., Yamato, H., Fukumoto, S., Sekine, K. Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice. Endocrinology. 140: 1005-1008, 1999 https://doi.org/10.1210/en.140.2.1005
- Darnay, B.G., Haridas, V., Ni, J., Moore, P.A., Aggarwal, B.B. Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase. J. Biol. Chem. 273(32):20551-20555, 1998 https://doi.org/10.1074/jbc.273.32.20551
-
Galibert, L., Tometsko, M.E., Anderson, D.M., Cosman, D., Dougall, W.C. The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-
$\kappa$ B, a member of the TNFR superfamily. J. Biol. Chem. 273: 34120-34127, 1998 https://doi.org/10.1074/jbc.273.51.34120 - Teitelbaum, S.L. Bone resorption by osteoclasts. Science. 289: 1504-1508, 2000 https://doi.org/10.1126/science.289.5484.1504
- Takayanagi, H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7: 292-304, 2007 https://doi.org/10.1038/nri2062
- Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J., Wagner, E.F., Mak, T.W., Kodama, T., Taniguchi, T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell. 3: 889-901, 2002 https://doi.org/10.1016/S1534-5807(02)00369-6
- Matsuo, K., Galson, D.L., Zhao, C., Peng, L., Laplace, C., Wang, K.Z., Bachler, M.A., Amano, H., Aburatani, H., Ishikawa, H., Wagner, E.F. Nuclear factor of activated T-cell(NFAT) rescues osteoclastogenesis in precursors lacking c-fos. J. Biol. Chem. 279: 26475-26480, 2004 https://doi.org/10.1074/jbc.M313973200
- Lee, S.E., Woo, K.M., Kim, S.Y., Kim, H.M., Kwack, K., Lee, Z.H., Kim, H.H. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone. 1: 71-77, 2002
- Tanaka, S., Miyazaki, T., Fukuda, A., Akiyama, T., Kadono, Y., Wakeyama, H., Kono, S, Hoshikawa, S., Nakamura, M., Ohshima, Y., Hikita, A., Nakamura, I., Nakamura, K. Molecular mechanism of the life and death of the osteoclast. Ann. N. Y. Acad. Sci. 1068: 180-186, 2006 https://doi.org/10.1196/annals.1346.020
- Matsumoto, M., Sudo, T., Saito, T., Osada, H., Tsujimoto, M. Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL). J. Biol. Chem. 275: 31155-31161, 2000 https://doi.org/10.1074/jbc.M001229200
- Chang, E.J., Ha, J., Huang, H., Kim, H.J., Woo, J.H., Lee, Y., Lee, Z.H., Kim, J.H., Kim, H.H. The JNK-dependent CaMK pathway restrains the reversion of committed cells during osteoclast differentiation. J. Cell. Sci. 121: 2555-2564, 2008 https://doi.org/10.1242/jcs.028217
- 이재복, 이병렬. 토사자약침의 항암작용 및 면역효과에 대한 실험적 연구. 대한침구학회지 18(3):94-104, 2001
-
May, M.J., D'Acquisto, F., Madge, L.A., Glockner, J., Pober. J.S., Ghosh, S. Selective inhibition of NF-
$\kappa$ B activation by a peptide that blocks the interaction of NEMO with the I$\kappa$ B kinase complex. Science. 289: 1550-1554 https://doi.org/10.1126/science.289.5484.1550 -
Jimi, E., Aoki, K., Saito, H., D'Acquisto, F., May, M.J., Nakamura, I., Sudo, T., Kojima, T., Okamoto, F., Fukushima, H., Okabe, K., Ohya, K., Ghosh, S. Selective inhibition of NF-
$\kappa$ B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nat. Med. 10: 617-624 - Yang, H.M., Shin, H.K., Kang, Y.H., Kim, J.K. Cuscuta chinensis extract promotes osteoblast differentiation and mineralization in human osteoblast-like MG-63 cells. J. Med. Food. 12(1):85-92, 2009 https://doi.org/10.1089/jmf.2007.0665
- Sambrook, P., Cooper, C. Osteoporosis. Lancet. 367: 2010- 2018, 2006 https://doi.org/10.1016/S0140-6736(06)68891-0
- Dougall, W.C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M.E., Maliszewski, C.R., Armstrong, A., Shen, V., Bain, S., Cosman, D., Anderson, D., Morrissey, P.J., Peschon, J.J., Schuh, J. RANK is essential for osteoclast and lymph node development. Genes Dev. 13: 2412-2424, 1999 https://doi.org/10.1101/gad.13.18.2412
- Asagiri, M., Sato, K., Usami, T., Ochi, S., Nishina, H., Yoshida, H. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202: 1261-1269, 2005 https://doi.org/10.1084/jem.20051150
- Mansky, K.C., Sankar, U., Han, J., Ostrowski, M.C. Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling. J. Biol. Chem. 277: 11077-11083, 2002 https://doi.org/10.1074/jbc.M111696200
- Ishida, N., Hayashi, K., Hoshijima, M., Ogawa, T., Koga, S., Miyatake, Y., Kumegawa, M., Kimura, T., Takeya, T. Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J. Biol. Chem. 277: 41147-41156, 2002 https://doi.org/10.1074/jbc.M205063200
- Rajotte, D., Sadowski, H.B., Haman, A., Gopalbhai, K., Meloche, S., Liu, L., Krystal, G., Hoang, T. Contribution of both STAT and SRF/TCF to c-fos promoter activation by granulocyte-macrophage colony-stimulating factor. Blood. 88: 2906-2916, 1996